k 76 carboxylic acid has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hing, K; Inoue, K; Izawa, T; Kinoshita, T; Miyazaki, W; Nakano, Y; Shinohara, M | 1 |
| Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S; Takata, M | 1 |
2 other study(ies) available for k 76 carboxylic acid and Bright Disease
| Article | Year |
|---|---|
Effects of K-76 monocarboxylic acid, an anticomplementary agent, on various in vivo immunological reactions and on experimental glomerulonephritis.
Topics: Anaphylaxis; Animals; Complement Inactivator Proteins; Complement System Proteins; Glomerulonephritis; Guinea Pigs; Hemolysis; Immune System; Lupus Erythematosus, Systemic; Mice; Mice, Inbred ICR; Passive Cutaneous Anaphylaxis; Rabbits; Rats; Rats, Inbred Strains; Sesquiterpenes | 1984 |
Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
Topics: Animals; Antibodies, Anti-Idiotypic; Antigen-Antibody Complex; Complement C5; Complement Inactivator Proteins; Glomerulonephritis; Kidney Glomerulus; Male; Proteinuria; Rats; Rats, Inbred SHR; Sesquiterpenes; Time Factors | 1987 |